Closing out his discussion on the port delivery system in retinal diseases, Chirag Jhaveri, MD, considers how this approach has impacted the treatment landscape.
Chirag Jhaveri, MD
Advertisement
Articles by Chirag Jhaveri, MD
Concise insight on education and training strategies that will optimize use of the port delivery system in retinal diseases.
Chirag Jhaveri, MD, reviews the trial design and results of the LADDER and ARCHWAY studies, which tested the port delivery system in neovascular AMD.
Expert insight on the history of the port delivery system in neovascular AMD and how it has impacted patient experience and outcomes.
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
Glaukos receives FDA approval for Epioxa topical therapy for keratoconus
2
Aurion Biotech releases positive 12-month results from phase 1/2 CLARA trial
3
Dompé's NAION program selected for FDA Commissioner’s National Priority Voucher Program
4
Q&A: Insights from Rajesh K. Rajpal, MD, on an incision-free keratoconus therapy
5
.png "Optometry Times"){kind=logo}
